A Study of XZP-3287 in Combination With Letrozole/Anastrozole in Patients With Advanced Breast Cancer
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Advanced Breast Cancer
Interventions: DRUG: XZP-3287+ Letrozole/Anastrozole|DRUG: Placebo + Letrozole/Anastrozole
Sponsor: Xuanzhu Biopharmaceutical Co., Ltd.